New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 18, 2018 - The FDA announced the approval of the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).
Download PDF
Return to publications
